Thanks for the heads up. Interesting that TLT itself would not PR this.
Sincerely hope they already have 1 or hopefully more patients already enrolled. Sincerely hope too that they manage to find a way to shorten the 3-year estimated time-frame for completion of study. As I recall finding eligible patients for earlier ph 1b study was quite difficult given all the parameters.
Obviously, the biggest hope is that the trial is successful -- for patients, the company and its shareholders.